By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Fluidigm today said it plans to offer more than 5 million shares of its common stock at between $13.50 and $15.50 per share in its planned initial public offering.
Registering provides access to this and other free content.
Already have an account?Login Now.
David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.
In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.
Adam Rutherford discusses genetic genealogy at the Guardian.
Portions of the US 21st Century Cures Act are raising some safety concerns.